Related Experiment Video
Updated: May 17, 2026

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
Implantation of left ventricular assist device complicated by undiagnosed thrombophilia
Ondrej Szarszoi1, Jiri Maly, Daniel Turek
1Department of Cardiovascular Surgery, Institute for Clinical and Experimental Medicine, 140 21 Prague 4, Czech Republic. onsz@medicon.cz
Insights
Left ventricular assist device implantation can reveal hidden thrombophilia, a blood clotting disorder. Pre-implantation screening is crucial for identifying patients with clotting risks before cardiac support.
Area of Science:
- Cardiology
- Hematology
- Medical Devices
Background:
- Dilated cardiomyopathy necessitates advanced cardiac support.
- Left ventricular assist devices (LVADs) are used for end-stage heart failure.
- Thromboembolic events are a known complication in cardiac patients.
Observation:
- A patient with dilated cardiomyopathy received an axial-flow LVAD.
- Post-implantation echocardiography identified a large left ventricular thrombus.
- The LVAD's inflow cannula remained unobstructed with adequate flow.
Findings:
- Laboratory tests revealed protein S deficiency, factor V Leiden mutation, and MTHFR C667T mutation.
- These findings indicate underlying thrombophilia.
- No significant suction events occurred during circulatory support.
Implications:
- LVAD implantation can unmask undiagnosed thrombophilia.
- Pre-operative screening for thrombophilia is recommended.
- Early identification of thrombophilia can guide patient management and improve outcomes.
Abstract:
A patient with dilated cardiomyopathy and no history of thromboembolic events received a surgically implanted axial-flow left ventricular assist device. After implantation, transesophageal echocardiography revealed a giant thrombus on the lateral and anterior aspects of the left ventricle. The inflow cannula inserted through the apex of the left ventricle was not obstructed, and the device generated satisfactory blood flow. Laboratory screening for thrombophilia showed protein S deficiency, heterozygous factor V Leiden mutation, and heterozygous MTHFR C667T mutation. During the entire duration of circulatory support, no significant suction events were detected, and the patient was listed for heart transplantation. Ventricular assist device implantation can unmask previously undiagnosed thrombophilia; therefore, it should be necessary to identify thrombophilic patients before cardiac support implantation.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Cardiac Catheterization III: Left Heart Catheterization
Venous Thrombosis I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
